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A B S T R A C T
Primers are arguably the single most critical components of any PCR assay, as their properties control the
exquisite speciﬁcity and sensitivity that make this method uniquely powerful. Consequently, poor design
combined with failure to optimise reaction conditions is likely to result in reduced technical precision and false
positive or negative detection of ampliﬁcation targets. Despite the framework provided by the MIQE guidelines
and the accessibility of wide-ranging support from peer-reviewed publications, books and online sources as well
as commercial companies, the design of many published assays continues to be less than optimal: primers often
lack intended speciﬁcity, can form dimers, compete with template secondary structures at the primer binding
sites or hybridise only within a narrow temperature range. We present an overview of the main steps in the
primer design workﬂow, with data that illustrate some of the unexpected variability that often occurs when
theory is translated into practice. We also strongly urge researchers to report as much information about their
assays as possible in their publications.
1. Introduction
The peer-reviewed literature contains references to tens, if not
hundreds of thousands of oligonucleotide primer sequences for use with
the polymerase chain reaction (PCR) and hundreds more are available
from primer databases or can be bought from commercial suppliers.
Oligonucleotide synthesis is available at bargain prices, enzymes are
becoming faster, more reliable and cheaper, there are task-speciﬁc
master mixes (e.g. for multiplexing) and thermal cyclers are becoming
more aﬀordable and user-friendly. This makes it possible to generate
huge amounts of data with comparatively little eﬀort. Since these data
ﬁnd their way into over 15,000 qPCR-related publication every year, it
is essential to try and ensure that publications report real results, rather
than technical bias [1].
With so many ready-made assays available, one might wonder why
anyone would want to go to the trouble of designing yet another assay.
Especially as the perception is that designing one’s own assay is a lot
more complex and inconvenient than simply buying it from a com-
mercial supplier, who in any case will have validated every one of their
assays. That perception is wrong for two reasons: ﬁrst, commercial
primers or assay condition may not have been experimentally validated
or optimised. Second, it cannot be presumed that a primer set will
generate the same results under diﬀerent experimental conditions since
assay performance can vary depending on what extraction methods was
used to purify the templates [2], what reagents were used for the PCR
reaction [3–5] and what thermal cycler was used to run the assays
[6,7]. Hence researchers can be sure of an assay’s performance only by
performing their own validation and optimisation experiments. Doing
this before working with precious samples will save time, expense and
help avoid failed runs or inconsistent experimental data. Given the
signiﬁcance of empirical validation, it is important that any publication
include that essential information [8–11]. Several reports have been
published recently that together scored thousands of peer-reviewed
papers in a wide collection of journals ranging from low to high impact
factors [12–17]. All concluded that the amount of critical information
provided with papers reporting qPCR data is inadequate for the purpose
of evaluating the validity of conclusions arising from those data, with
many not reporting primer sequences, validation data or including
wrong information.
The main concerns with regards to designing assays usually relate to
researchers being unfamiliar with the primer design process or unsure
about the key parameters most likely to generate optimal primers,
lacking the appropriate design tools and apprehension that the design
process will take too long. However, assay design is usually quite
straightforward, suitable tools are freely available online and it takes
less time to design a robust, sensitive and speciﬁc assay than to trou-
bleshoot a poorly designed one.
We provide a concise overview of the main primer-related issues
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that confront anyone wanting to design a qPCR assay, consider the main
criteria that have an impact on assay performance, dissect the in-
dividual steps of the assay design workﬂow and analyse the perfor-
mance of some real-life assays.
2. The importance of primers
Appropriately validated primers are crucial in determining the
speciﬁcity, sensitivity and robustness of a PCR reaction [18]. Whilst it
nearly always possible to get a result with a PCR assay, this is not the
same as getting a correct result, be that a present/absent call for the
detection of a pathogen or mutation using an endpoint assay or an
accurate quantiﬁcation of RNA copy numbers using a real-time method.
In reality, PCR is not as robust as many people believe and there is a
need to consider the science underlying DNA folding and match versus
mismatch hybridisation. Having said that, it is not always obvious why
some primer combinations work, or indeed do not work well.
The critical variable for primer performance is its annealing tem-
perature (Ta), rather than its melting temperature (Tm), as the Ta de-
ﬁnes the temperature at which the maximum amount of primer is
bound to its target. The optimal primer Ta must be established experi-
mentally as primer design programs generally calculate Tms and, in any
case, many use wrong prediction parameters [19]. Furthermore, since
optimal annealing temperatures vary with diﬀerent buﬀers, results
obtained with one master mix cannot necessarily be extrapolated to a
second one. Even at the optimal Ta, non-speciﬁc ampliﬁcation can
occur, especially with “proofreading” enzymes, caused not just by
primer dimers but by physical closeness of primer pairs at mismatched
sites. Furthermore, reliance on BLAST searches alone does not guar-
antee primer speciﬁcity, since whilst the BLAST algorithm returns fast
results it may miss thermodynamically important hybridisation events
as it does not correctly score the gaps that generate duplex bulges [19].
Furthermore, the eﬀects of mismatches on duplex stability are sequence
context dependent and are not correctly called by sequence in-
dependent approximations [20].
3. Principal considerations for assay design
A good assay will not create primer dimers, be close to 100% eﬃ-
cient and exquisitely speciﬁc. Such an assay will also be robust, which
means that if conditions are not quite optimal, for example if a sample
contains traces of an inhibitor, or if the thermal cycler has uneven
thermal proﬁles across its block, then the assay may still perform re-
liably and generate usable data. In contrast, a poor assay will be much
more susceptible to variable conditions, and is virtually guaranteed to
result in wasted time and considerable frustration on the part of the
researcher. As a rule of thumb, if primers perform well over a broad
temperature gradient, the assay tends to be robust, whereas if ampli-
ﬁcation is restricted to a narrow temperature optimum, it is not.
When designing assays in-house, the design process comprises a
comprehensive workﬂow that demands careful consideration not just of
the primers themselves but also of amplicon uniqueness, structure and
location, with the aim of bringing about an optimal primer/amplicon
combination for accurate quantiﬁcation of nucleic acids. Attention to
such detail makes it more likely that the assays will yield data that are
suﬃciently reliable and sensitive to generate consistent as well as
biologically/clinically relevant results. Importantly, even when the
primers have been designed by a colleague, tracked down from a peer-
reviewed publication, acquired from a primer database or purchased
from a commercial source, reliable qPCR demands a retrospective
evaluation of most of the in silico criteria and assiduous validation of all
of the wet lab parameters.
Achieving these objectives is not diﬃcult, when following the
workﬂow shown in Fig. 1 which involves four major steps: (i) target
identiﬁcation, (ii) deﬁnition of assay properties, (iii) characterisation of
primers and (iv) assay optimisation. The ﬁrst two steps are carried out
by in silico analyses, the latter two by experimental investigation
4. Target identiﬁcation
It is self-evident that an assay is useful only if the correct target has
been identiﬁed and used for assay design. Hence the more that is known
about the DNA or RNA of interest, the better. Accordingly, the ﬁrst step
involves accumulating as much information as possible from sequence
databases. This can appear to be quite daunting, but will soon become
second nature with a systematic, step-by-step approach. One problem
with searching for sequences is that there are often numerous identical,
closely-related or, more surprisingly, signiﬁcantly diﬀerent sequences
listed under the same common name. An NCBI search for “Aspergillus
terreus 18S” brings up 161 sequences of varying lengths, descriptions
and accession numbers. A search for “Aspergillus terreus 28S” returns
142 sequences, some the same as the previous search, but again all with
diﬀerent accession numbers and lengths. There are two lessons here: (i)
it is essential to have absolute clarity about the ampliﬁcation target and
(ii) it is crucial always to refer to the accession or individual transcript
number of any sequence used for assay design, as this minimises the risk
of confusion and makes life much simpler for reviewers and readers.
Furthermore, many databases are not curated, so a given sequence
name is solely based on what the individual who uploaded it thought it
was. Consequently, if the original sequence was incorrect, for example
due to a nonspeciﬁc PCR, but this was not known when it was up-
loaded, then a circular problem will arise that further propagates the
error.
Database mining assumes familiarity with its nomenclature: e.g.
NCBI sequences preﬁxed with NC_, NG_ are curated genomic sequences,
NM_ is a curated mRNA sequence, whereas NT_ and NW_ are automated
genomic and XM_ automated RNA sequences. Hence the information
with regards to some sequences (NM_) is likely to be more reliable than
that for others (XM_) and judicious choice of sequence information is
advised. For example, if the aim is to amplify a cellular mRNA, it is
important to ascertain whether there are transcript or splice variants or
additional closely related paralogues and whether the assay should
target all of those or be able to distinguish between them. One im-
portant consideration is to ensure that the assay does not inadvertently
amplify pseudogenes. Designing PCR primers for miRNAs is somewhat
more challenging, since a typical miRNA is only 22 bases long, which is
about the same size as a conventional PCR primer. Genotyping assays,
on the other hand, place an obvious restriction on the position of the
amplicon as it must include the site of the polymorphism or mutation.
This highlights an important point in that while designing an optimal
assay is desirable the designer is ultimately at the mercy of the sequence
in question and the ‘best’ assay may not be ideal. This may not preclude
its use as long as the limitations of such a choice (such as possible re-
duced eﬃciency, sensitivity or precision) are understood and, crucially,
reported in any publication.
Absolute certainty as to what is being targeted is of particular im-
portance when utilising PCR as a diagnostic or forensic test. Whilst
assays used in clinical applications are heavily regulated (although
mistakes are still made), research diagnostic assays are not, so factors
such as speciﬁcity must be considered when reaching conclusions.
Human papillomavirus (HPV) is the primary aetiological factor that
transforms cervical epithelia into cervical cancer and causes most anal
and oropharyngeal as well as some vaginal, vulvar, and penile cancers.
According to epidemiological case-control studies, 15 high-risk HPV
types have been acknowledged, while three types have been designated
as probable high-risk and 12 types have been classiﬁed as low-risk [21].
Depending on the purpose of an associated study it could be essential to
distinguish between these subtypes and so appropriately designed as-
says will be paramount [22]. Similarly, designs targeting bacterial and
fungal pathogens require careful consideration prior to carrying out any
diagnostic experiments [23]. The recent interest in using RT-PCR to
target RNA for the tissue proﬁling of human forensic samples [24]
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Fig. 1. Workﬂow for PCR primer design. The fol-
lowing web sites are pertinent: PrimerBlast: https://
www.ncbi.nlm.nih.gov/tools/primer-blast;
DINAmelt: http://unafold.rna.albany.edu/?q=
DINAMelt; Mfold: http://unafold.rna.albany.edu/?
q=mfold; BLAST: https://blast.ncbi.nlm.nih.gov/
Blast.cgi; Ensembl: http://www.ensembl.org/index.
html;.
Fig. 2. Temperature gradient analysis of three assays targeting fungal rRNA genes. Eﬀect of diﬀerent commercial master mixes on gradient proﬁle. Ampliﬁcation was carried out in 10 μL
using BioRad’s iTaq Universal SYBR Green Supermix (172-5121) with 300 nM ﬁnal primer concentration on a BioRad CFX instrument, with a three minute 95 °C denaturation step
followed by 40 cycles of 5 s at 95 °C and 30 s at 62 °C. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Primers were Asp-F: CTTGGATTTGCTGAAGACTAAC and Asp-R: CTAACTTTCGTTCCCTGATTAATG, amplicon size 76 bp. This assay is robust, with the ampliﬁcation plots virtually
indistinguishable at the eight temperatures tested. B: Melt curve. C. Primers were FS1-F: GAGGATGCTTTTGGTGAG and FS1-R: GAGCTTTACAGAGGATCG, amplicon size 99 bp. This
assay is somewhat less robust, recording visible diﬀerences in Cq. D: Melt curve. E. Primers were FS2-F: CCCGAGTTGTAATTTGTAG and FS2-R: GAAGGAGCTTTACAGAGG, amplicon size
121 bp. This assay is poor, with signiﬁcantly higher Cqs at temperatures away from the optimum. F: melt curve. G. Table of the Cqs recorded for the three assays, with the assays recording
ΔCqs of 0.53, 1.63 and 8.93, respectively, between optimal (highlighted in red) and least optimal temperatures. Ampliﬁcation conditions were as described in the legend to Fig. 5.
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makes it necessary to ensure that the new assays being developed are
species-, RNA- and tissue-speciﬁc. It is particularly worth noting that
when the intention is to achieve RNA-speciﬁcity by placing the primer
binding sites in separate exons, intron size is important. At least one fast
Taq polymerases in use today can extend at a rate of 155 nucleotides/
second [25], and with annealing and polymerisation times of tens of
seconds, as is still common, this can result in polymerisation through
the intron and the detection of ampliﬁed DNA, eliminating any chance
of reliably distinguishing tissue-speciﬁc RNA expression from DNA
contamination.
Surprisingly, many assays in clinical use are not as speciﬁc and/or
sensitive as one might expect, making one wonder whether or how they
were ever optimised. A publication reporting the evaluation of the
performance of eight candidate working standards developed for di-
agnostic qPCR-based assays of clinically relevant viral targets by
Central Veterinary Laboratories in the UK showed a high level of
variability in intra- and inter-assay detection of their targets, with the
highest levels of variation amounting to almost 3 logs of virus [26]. This
is rather disturbing, seeing that these results come from laboratories
carrying out routine RT-qPCR analyses on patient samples. Other re-
ports describe exon-speciﬁc primers that also may bind to introns [27],
where the probe binds to sequences upstream from the forward primer
[28] or where some of the published primer sequences are incorrect
[29].
5. Assay properties
5.1. Primers
The discussion in the previous section highlights the importance of
considering assay design as an integration of amplicon and primer
characteristics. Primers are the pivotal component of a qPCR assay:
their raison d'être is to prime the speciﬁc ampliﬁcation of a single target
in a background of more-or-less related potential alternatives. Most
assays are designed to run under constant PCR conditions, consisting of
a brief 95 °C melt followed by a single annealing and elongation step of
60 °C as this lends itself to automation and the running of diﬀerent
assays using the same parameters. However, as most polymerases used
for PCR work best at 72 °C, our advice is to consider designing assays
where primers hybridise at higher temperatures (63 ± 2 °C). This also
helps reduce the polymerisation time and so speeds up the time re-
quired to complete a PCR run [30]. Since oligonucleotides are cheap, it
is worth designing several primers for each assay and choosing the
combination giving the lowest Cq and the least amount (ideally none)
of primer dimer. This could be a problem if the aim of the assay is
ultimate sensitivity.
The Ta characteristics of PCR primers can vary widely. Some assays
are not suﬃciently robust and fall apart quickly if they are not per-
formed at the optimal Ta of the primers. The temperature proﬁles of
three assays amplifying diﬀerent targets are demonstrated in Fig. 2,
Fig. 3. Eﬀect of diﬀerent commercial master mixes on gradient proﬁle. Ampliﬁcation reactions were carried out as described in the legend to Fig. 2, except that seven diﬀerent master
mixes were used and annealing was carried out using a temperature gradient from 60 °C–65 °C.
A. Primers CA-F: GTTTGGTGTTGAGCAATAC and CA-R: CTACCTGATTTGAGGTCAAA were used to amplify fungal genomic DNA and PCR amplicons were detected with a hydrolysis
probe CA-Pr: FAM-ACAATGGCTTAGGTCTAAC-BHQ. All master mixes record similarly robust gradient proﬁles, although the Cqs from one master mix are lower than those from the rest.
The optimal annealing temperatures are highlighted in red and diﬀer between the master mixes.
B. A. Primers BAR-1F: CATGCTCCAAAATGCCCTA and BAR-1R: CTTGGTAGCACACCCAAA were used to amplify bacterial genomic DNA and PCR amplicons were detected with SYBR
Green chemistry. The quality of the gradient proﬁle depends on the master mix used, although the speciﬁcity is not aﬀected, as determined by the melt curves. The optimal annealing
temperatures are highlighted in red and diﬀer between the master mixes.
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where there is a clear diﬀerence in the results obtained for the three
primer sets. The assay in panel A is optimal and characterised by a
broad optimal Ta range with similar Cqs (maximum ΔCq = 0.53) over a
59 °C–64 °C range. The assay in panel B is not quite as robust, with a
maximum ΔCq of 1.63, whereas the assay in panel C has a narrow
optimum range between 59 °C and 60 °C, resulting in signiﬁcantly
lower Cqs away from that optimum (ΔCq = 8.93). This is quite separate
from the speciﬁcity of the ampliﬁcation reaction, where the melt curves
reveal a single peak indicative of the assay remaining speciﬁc at the
temperatures tested (panels D, E and F). Unfortunately, it is not possible
to come up with a fail-safe prediction of which primers or combinations
of primer will generate the most temperature-tolerant, eﬃcient, or
speciﬁc assays. Hence any in silico design must be followed by experi-
mental validation and optimisation. This takes time, eﬀort and costs
money − but is an integral part of performing a PCR assay and the
more thorough the experimental validation, the more likely any sub-
sequent results will be accurate and not the product of measurement
error that has no true biological meaning.
A major consideration is the fact that diﬀerent assays perform dif-
ferently with diﬀerent master mixes, so there is no one size ﬁts all rule.
This is shown in Fig. 3, where two primer sets show signiﬁcantly dif-
ferent properties. Primer set A records a robust temperature gradient
proﬁle with seven master mixes, although one of the master mixes re-
cords much higher Cqs than the rest. In contrast, the results obtained
primer set B depend on what master mix was used: three master mixes
have a proﬁle that is similarly robust to primer set A, the other four
record signiﬁcantly less robust proﬁles, with one especially poor.
Primer concentrations for SYBR I Green assays tend to be lower
(100–400 nM) than for probe-based assays (300–900 nM), but there are
always exceptions that prove that rule. The eﬀects of varying primer
concentrations can diﬀer dramatically between diﬀerent primer pairs.
Sometimes the eﬀects can be dramatic and extend over several mag-
nitudes, with primer combinations from 50 to 600 nM resulting in a Cq
range of more than 20 cycles [31]. Generally, however, the eﬀects are
less pronounced as long as primer concentration does not dip below
100 nM, and of concern mainly if sensitivity is the major consideration.
This is demonstrated in Fig. 4, where two primer sets at two con-
centrations were used with ﬁve diﬀerent master mixes. The results
demonstrate that optimal primer annealing and concentration condi-
tions are aﬀected by the master mix, with diﬀerent suppliers using
diﬀerent Mg2+ concentrations and adding undisclosed stabilisers to
their buﬀers. Unfortunately, the results are not consistent between
primers and master mixes. Master mixes B-E record higher Cqs with
higher primer concentrations for one of the primer sets, whereas master
mix A records lower Cqs (Fig. 4A). Yet master mixes B-E record lower
Cqs with higher primer concentrations for the second set of primers
(Fig. 4B). Hence annealing conditions may need to be re-evaluated
when switching from one master mix to another.
qPCR assays generally use symmetric primers. However, this results
in the reactions typically slowing down and entering the plateau phase
in a stochastic manner, because reannealing of the template strands
gradually outcompetes primer and probe binding to the template
Fig. 4. Master mix-dependent eﬀects of primer concentration. Ampliﬁcation was carried using ﬁve commercial master mixes and conditions, except for primer concentration, were as
described in the legend to Fig. 2.
A. Primers CA-F and CA-R were used at either 300 nM or 600 nM ﬁnal concentration to amplify fungal genomic DNA and PCR amplicons were detected with SYBR Green chemistry.
Doubling the primer concentration has a small deleterious eﬀect with most master mixes, with the maximum eﬀect an increase in Cq of 1.3.
B. Primers BAR-1F and BAR-1R were used at either 300 nM or 600 nM ﬁnal concentration to amplify bacterial genomic DNA and PCR amplicons were detected with SYBR Green
chemistry. Doubling the primer concentration has an enhancing eﬀect with all master mixes, with the maximum eﬀect a decrease in Cq of 2.3.
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strands and sequesters the polymerase. This is a particular problem
when the aim is to detect speciﬁc DNA targets down to alleles of single-
copy genes in single cells. Asymmetric PCR potentially circumvents the
problem of amplicon strand reannealing by using unequal primer
concentrations. However, asymmetric ampliﬁcation can be much less
eﬃcient and requires extensive optimisation to identify the proper
primer ratios, the amounts of starting material, and the number of
ampliﬁcation cycles that can generate reasonable amounts of product
for individual template/target combinations. This issue is addressed by
LATE-PCR, which uses unequal primer concentrations but takes into
account the eﬀect of the actual primer concentrations on primer an-
nealing [32]. It corrects for the fact that the optimal Ta of the limiting
primer is often several degrees below the Ta of excess primer and allows
the asymmetric PCR to proceed as eﬃciently as symmetric PCR [33].
Furthermore, single stranded amplicons are generated with predictable
kinetics for many cycles beyond the exponential phase. This permits
uncoupling of primer annealing from product detection via a ﬂuor-
escent probe. As a result, the Ta of the probe no longer needs to be
higher than the Tm of either primer. This permits the use of low-Tm
probes, which are inherently more allele-discriminating, generate lower
background, and can be used at saturating concentrations without in-
terfering with the eﬃciency of ampliﬁcation [34].
5.2. Amplicons
Reliable ampliﬁcation and precise quantiﬁcation requires complete
doubling of target at each PCR cycle. Hence PCR amplicons detected by
probes are generally short, as the suboptimal elongation temperature,
generally 60 °C, does not always result in completed products that can
be used as templates in further ampliﬁcations [35]. Nevertheless, the
choice of amplicon size depends on usage and for some applications
longer amplicons work better [36,37]. With SYBR Green, one might
expect longer PCR amplicons to result in lower Cqs, since they can bind
more SYBR Green molecules. However, this expectation is not always
born out in practice and shorter amplicons can record lower Cqs than
longer ones [35]. This is illustrated by a comparison of the performance
of three assays A, B and C, which target the same gene in the human
intestinal pathogen Clostridium diﬃcile. The assays amplify sequences
1532–1680, 3589–3710 and 1423–1498 respectively of the bacterial
toxin B (tcdB) gene (NC_009089) (Fig. 5A). An Mfold analysis [38]
suggests that the three PCR amplicons, comprising 149, 121 and 76 bp,
are free from signiﬁcant secondary structure, with all primer binding
sites accessible for primer annealing (Fig. 5B). This is probably helped
by the high AT content of the bacterial DNA. Assay A records a Cq of
27.25, whereas assay B records a Cq of 26.14, i.e. the shorter amplicon
is detected 1.1 cycles earlier than the longer amplicon (Fig. 2C). The
melt curves are similar, showing a single peak for either assay, with
amplicon B having a slightly lower peak at 75 °C, compared with peak
for amplicon A at 76 °C.
In contrast, a comparison between amplicons B and C generates the
expected result: B is signiﬁcantly longer (121 bp) than amplicon C
(76 bp) and records a Cq of 26.14, whereas assay C records a Cq of
Fig. 5. Comparison of Clostridium diﬃcile assays targeting the toxin gene tcdB.
A. Location of the assays. Amplicon A (blue) is 149 bp, amplicon B (green) is 121 bp and amplicon C (black) is 76 bp. The primers for assay A are tcdB-FA:
GTCCATCCTGTTTCCCAAGCAA, tcdB-RA: AGCCACACTTATCTATATATGACGTATTGGA, those for assay B are tcdB-FB: CAACTGAACAAGAAATGGCTAGCTT and tcdB-RB:
CTCCTTGTCAACTACTATATTTTGAG, those assay C are tcdB-FC: GCGGCAGCTTATCAAGATTT and tcdB-RC: TTCTTAAATCAGCTTCTATCAAATGG.
B. Mfold analysis indicates no secondary structure issues at the primer binding sites.
C. Ampliﬁcation plots and melt curves for the PCR amplicons A and B. D. Ampliﬁcation plots and melt curves for the PCR amplicons B and C. The blue, green and black data were obtained
for amplicons A, B or C, respectively. Ampliﬁcation conditions were as described in the legend to Fig. 2.
S. Bustin, J. Huggett Biomolecular Detection and Quantification 14 (2017) 19–28
24
27.87, i.e. the longer PCR amplicon is detected 1.7 cycles earlier than
the short one. In general, too short an amplicon, (< 80 bp) in SYBR
Green assays may result in diﬃculties when diﬀerentiating amplicon
and primer dimer(s) and can result in later Cq readings. Hence it is a
good idea to keep SYBR Green amplicons a little longer (80–150) than
those targeted by probe-based assays (60–90). In addition, SYBR Green
has a greater aﬃnity for AT–rich than GC–rich DNA, hence G-C rich
PCR amplicons may record higher Cqs than A-T rich ones.
Melt curve analysis is also not always what it seems as, since
whereas SYBR Green intercalates at low dye:base pair ratios, at higher
ratios its conformation changes and it interacts with the minor groove
[39]. It is this interaction that results in a signiﬁcant increase in
ﬂuorescence. An important characteristic of SYBR Green binding to
DNA is that in PCR the dye:base pair ratio is not constant, since it
changes with cycle number as more double stranded DNA is produced.
Consequently, melt curve analysis can be inﬂuenced by the number of
cycles and the amount of DNA present after ampliﬁcation.
Amplicons should always be checked for secondary structure, as
areas of extensive secondary structure can be an important cause of
reduced ampliﬁcation eﬃciency. Possible structures must be checked
using the actual reaction conditions, especially the Ta, salt and Mg2+
ion concentrations and the simplest way to check secondary structures
is by using the Mfold website. The hybridisation kinetics of the an-
nealing reaction will favour intramolecular binding, obstruct primer
binding, reduce priming eﬃciency and hence reduce the ampliﬁcation
eﬃciency [40]. Hence the binding regions for primers should be com-
pletely accessible; if the predictions suggest any secondary structures at
those sites, the amplicon should, where possible, be moved. If the price
of avoiding secondary structures at the primer binding sites is a longer
amplicon, then that may be a price worth paying, especially with the
introduction of the latest fast reagents.
Of course, the secondary structures are only predictive, and it may
also be necessary to consider the sequences directly upstream or
downstream from the amplicon, as they could interfere with the initial
stages of the PCR assay [41]. The GC content of amplicons should be as
close to 50% as possible and the inclusion of Guanine (G) repeats
should be avoided, since they may prevent complete strand dissociation
and so also reduce ampliﬁcation eﬃciency.
However, it is important to realise that these are general rules and in
practice, an assay that ampliﬁes a longer product can perform better
than a shorter one, many bacterial PCR amplicons will be AT rich and
sometimes secondary structures just cannot be avoided. Consequently,
although there are guidelines for everything, in practice things often
work out diﬀerent than theory asserts and in the end, all that matters is
how a design works in the laboratory. If all else fails, as long as the
assay is speciﬁc, most other conditions can be tweaked to achieve a
satisfactory eﬃciency. Most importantly, if despite all best eﬀorts an
assay is only 85% eﬃcient, then it is acceptable to report the results
Fig. 6. Eﬀects of diﬀerent master mixes on ampliﬁcation. Ampliﬁcation reactions were carried out as described in the legend to Fig. 2.
A. A qPCR assay targeting fungal DNA was used with two sets of forward and reverse primers, which diﬀer mainly at their 3′-ends. The PCR amplicon has no secondary structure issues at
the primer binding sites.
B. When used with master mix A, the maximum ΔCq between the primer combinations was 4.64, the equivalent of a 25-fold diﬀerence in sensitivity. The assays using CA-R recorded the
lowest Cqs, whereas those using CA-RB recorded higher Cqs. When used with master mix B, the maximum ΔCq between the primer combinations was 2.98, the equivalent of an 8-fold
diﬀerence in sensitivity. The assay using CA-F/CA-R recorded the lowest Cqs, with the other three broadly equivalent.
C. Melt curves for master mixes A (green) and B (blue) show that the speciﬁcity of the assays is the same for all primer combinations.
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together with supporting evidence to show standard curves, report
precision and limits of quantiﬁcation and of detection. Thus, the lim-
itations of such an approach can be determined and validity of asso-
ciated conclusions evaluated.
6. Assay optimisation
The precision and reliability of a qPCR assay depends on rigorous
optimisation of every aspect of the PCR reaction. In some cases assays
may not require extensive optimisation, but for qPCR assays that are
performed for challenging measurement such as the precise quantiﬁ-
cation of small diﬀerences in nucleic acid quantities (be they DNA or
RNA), reliable detection of pathogens with good sensitivity or speciﬁc
discrimination of polymorphisms or mutations this is not the case.
Thorough optimisation of the PCR protocol, reagents, instrumentation
and analysis methodologies are a critical prerequisite for obtaining
valid, reproducible results with maximum speciﬁcity and sensitivity.
Incidentally, sensitivity is not dependent on a given Cq value; high
sensitivity is achieved if an assay can reliably amplify and detect low
copy number targets. While high detection sensitivity may not be ne-
cessary for a given experiment, it is worth remembering that a well
optimised qPCR is able to amplify single molecules of DNA and this
ability usually goes hand in hand with high eﬃciency and quantitative
precision.
The results shown in Fig. 6 demonstrate the eﬀects of using an
optimised primer/master mix combination. The assay is targeting
fungal DNA and forward and reverse primers bind to regions of the PCR
amplicon that are free from secondary structure. There are two forward
and two reverse primers and when used in all possible combinations it
is evident that with master mix A the CA-F/CA-RB grouping is the worst
grouping, as the Cqs translate into assays that are between 8- and 25-
fold less sensitive than those using the CA-R primer. In contrast, only
the CA-F/CA-R combination works optimally with master mix B, with
the other three recording similar, higher Cqs. The melt curves obtained
using the two master mixes are slightly diﬀerent, which is not un-
expected as they contain diﬀerent ingredients.
Quantiﬁcation by qPCR assumes a linear relationship between the
logarithm of the initial template quantity and the Cq value obtained
during ampliﬁcation. This permits calculations of an assay’s ampliﬁ-
cation eﬃciency and delineating its limits of detection and quantiﬁca-
tion [42]. The hallmarks of an optimised qPCR assay are:
• High ampliﬁcation eﬃciency (95–105%)
• Linear standard curve (R2 > 0.980)
• High precision between experimental experiments
• Consistency across replicate experiments
• No primer dimers
• Wide dynamic range
Ampliﬁcation eﬃciency is best determined by generating a standard
curve using serial dilutions of a template and determining the slope
from the linear regression of a plot of Cq (y-axis) vs log [quantity] [43].
If perfect doubling occurs with each ampliﬁcation cycle, the spacing of
the ﬂuorescence curves will be determined by the equation
2n = dilution factor, where n is the number of cycles between curves.
For example, with a 10-fold serial dilution of DNA, 2n = 10. Therefore,
n = 3.32 and the Cq values should increase by approximately 3.32
cycles for every ten-fold dilution. An acceptable evaluation of PCR
Fig. 7. Linearity of a well-designed qPCR assay. Ampliﬁcation reactions
were carried out as described in the legend to Fig. 2. Ten-fold serial di-
lutions of target DNA were subjected to ampliﬁcation with the Asp-F and R
primers. The variability recorded by the four replicates increases with
decreasing target copy number, until the nominal single copy target fails
to record a Cq in 4/5 replicates.
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eﬃciency requires a minimum of three replicates and four, ideally ﬁve,
orders of magnitude of template concentration. This is because even if
the assay is 100% eﬃcient, variability in the dilutions will result in a
range of eﬃciencies when testing a dilution series of a single log. A
slope of −3.32 reﬂects an eﬃciency of around 100%. A PCR reaction
with lower eﬃciency will have lower sensitivity [5,44].
The R2 value is the square of the correlation between the response
values and the predicted response values and measures how successful a
ﬁt is in explaining the variation of the data. R2 can take on any value
between 0 and 1, with a value closer to 1 indicating that a greater
proportion of variance is accounted for by the model. For example, an
R2 value of 0.998 means that the ﬁt explains 99.8% of the total var-
iation in the data about the average. An R2 value> 0.980 provides
good conﬁdence in correlating Cq and target copy number.
The ampliﬁcation plots and standard curve shown in Fig. 7 illustrate
a typical optimised qPCR assay. It shows good linearity over a wide
dynamic range from 1 × 108 copies all the way down to a nominal
single copy. A wide dynamic range of a well-designed assay is one of the
key features of qPCR assays and ensures that target copy numbers
varying by vast amounts can be accurately quantiﬁed.
If assays are well-designed and properly optimised, it should be
possible to get comparable results from separate assays that use the
same master mix to detect the same target gene or genome, but amplify
diﬀerent regions on that target. This implies that if two laboratories use
optimised assays to amplify, for example, the same mRNA, their results
should be equivalent. The example in Fig. 8 demonstrates this nicely.
Fig. 8A shows the location of assays amplifying exons 5/6 (A) or exons
7/8 (B) of the hypoxia inducible factor 1, alpha subunit transcript
variant 2 gene (NM_181054). An analysis of the secondary structures
indicates that there are none at the primer annealing sites (Fig. 8B). The
ampliﬁcation plots in Fig. 8C obtained over a temperature gradient
from 55 °C to 65 °C on a BioRad CFX conﬁrm that both assays are
comparable and robust in performance resulting in comparable Cqs,
with a single peak detected in the melt curve analysis. Standard curves
are also similar, with comparable ampliﬁcation eﬃciencies (Fig. 8D).
However, it must be remembered that while general fold-change dif-
ferences, especially large ones, may be easier to reproduce, it is far
more challenging to obtain comparable absolute quantities. This is
Fig. 8. Comparability of two optimised qPCR assays targeting the same gene HIF-1α (NM_181054.2). Ampliﬁcation reactions were carried out as described in the legend to Fig. 2, except
that annealing was carried out using a temperature gradient from 55 °C–65 °C.
A. Exon/intron structure of the gene, with assay 1 (HIF-AF: CCGAGGAAGAACTATGAA and HIF-AR:TGGTTACTGTTGGTATCA) amplifying sequences in exons 5 and 6 and assay 2 (HIF-
BF: AAGAACTTTTAGGCCGCTCA and HIF-BR:TGTCCTGTGGTGACTTGTCC) amplifying sequences in exons 7 and 8.
B. There are no secondary structures issues at the primer binding sites.
C. Both assays are robust, with the 55°–65° gradient recording similar qs of 24.68 ± 0.07 and 24.32 ± 0.12, respectively. Melt curve analysis shows a single peak.
D. Standard curves are comparable, showing linearity at least over ﬁve orders of magnitude.
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because upstream steps prior to the ampliﬁcation step, such as nucleic
extraction and reverse transcription, can contribute considerable un-
certainty [45] and employing comparable calibration standards is far
from trivial.
7. Conclusions
Knowledgeable and consistent assay design is at the heart of any
research project designed to quantify nucleic acids. It must be carried
out with care, but can be simpliﬁed by following a straightforward
workﬂow, as is detailed above. Reliable qPCR demands good primers.
This usually means absolute speciﬁcity, absence of hairpin structures or
cross-dimerisation potential and temperature tolerance. Good assay
design must consider amplicon structure and ensure that primer target
sites are free from secondary structure. There are numerous opinions
and guidelines available; an internet search for the terms “qPCR assay
design” lists 695,000 pages. However, many of these are based on
myths or may have been appropriate for legacy PCR but require subtle
(or not so subtle) modiﬁcations for use with qPCR. Each “new” assay
must be properly validated, with in silico validation acting as an initial
ﬁlter to screen designs and dismiss those that do not fulﬁl clearly de-
ﬁned quality criteria. Empirical optimisation and validation are an es-
sential, yet frequently neglected, part of any qPCR experiment. This
applies to both newly designed assays as well as assays obtained from
elsewhere. Finally, results of optimisation and validation processes
should be reported when qPCR data are published.
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